What is the appropriate inpatient management for a neutropenic patient receiving chemotherapy and radiation for small cell lung carcinoma who has possible black‑mold exposure, probable shingles, and a swollen throat with a raspy voice but no airway compromise?

Management of Neutropenic Patient with Small Cell Lung Cancer

This patient requires immediate hospitalization with urgent initiation of broad-spectrum IV antibiotics within 2 hours, along with antiviral therapy for presumed shingles and close monitoring for potential airway compromise. 1

Immediate Actions (Within 2 Hours)

1. Risk Stratification

This patient is high-risk based on:

• Profound neutropenia (ANC 0.30 × 10⁹/L, well below 500 cells/mm³)
• Active chemotherapy and radiation for small cell lung cancer
• Respiratory symptoms with throat swelling
• Possible concurrent viral infection (shingles)

High-risk patients require hospitalization and IV empirical antibiotics 1. The combination of severe neutropenia and respiratory symptoms makes outpatient management inappropriate, regardless of fever status 1.

2. Empirical Antibiotic Therapy

Start immediately with monotherapy using an anti-pseudomonal β-lactam:

• Cefepime (preferred), OR
• Meropenem or imipenem-cilastatin, OR
• Piperacillin-tazobactam 1

Add vancomycin to the initial regimen because this patient has:

• Respiratory symptoms with possible pneumonia
• Throat swelling suggesting potential soft tissue infection
• Hemodynamic risk given the clinical presentation 1

The guideline explicitly states vancomycin should be added for suspected pneumonia or when the patient's condition is unstable 1.

3. Antiviral Therapy for Shingles

Start acyclovir immediately (or valacyclovir) for presumed varicella-zoster virus reactivation 1. Do not wait for confirmation—treatment is indicated with clinical evidence of active viral disease 1. In neutropenic patients, disseminated VZV can be life-threatening.

4. Diagnostic Workup

Obtain immediately:

• Chest radiograph (mandatory for respiratory symptoms) 1
• Blood cultures from peripheral sites and any central venous catheter (before antibiotics if possible, but do not delay antibiotics) 1
• CBC with differential, serum creatinine, BUN 1
• Throat swab for bacterial culture
• Consider VZV PCR or direct fluorescent antibody testing if vesicular lesions present

Consider CT chest if chest X-ray is negative but symptoms persist, as pneumonia during neutropenia can progress rapidly and CT may reveal occult infiltrates 1. High-risk patients with persistent symptoms warrant CT imaging to assess for occult fungal infection 1.

Airway Management

The raspy voice and throat swelling require immediate ENT or anesthesia consultation for airway assessment. While there is no current airway compromise, neutropenic patients can deteriorate rapidly. Have equipment ready for emergent intubation. Consider:

• Serial examinations every 2-4 hours initially
• Fiberoptic laryngoscopy to assess degree of supraglottic edema
• ICU-level monitoring if any progression

The throat swelling could represent:

• Bacterial pharyngitis/epiglottitis (covered by empirical antibiotics)
• Radiation-induced mucositis (supportive care)
• Fungal infection if prolonged neutropenia (consider if no improvement in 3-5 days)

Black Mold Exposure Considerations

Do not empirically treat for invasive mold infection at this time. The IDSA guidelines recommend mold-active antifungals only after:

• Persistent fever despite 4-7 days of appropriate antibiotics, OR
• High-risk features with prolonged neutropenia (>7 days expected) 1

However, maintain high suspicion. If fever persists beyond 4-5 days or respiratory symptoms worsen:

• Obtain CT chest and sinuses to evaluate for invasive aspergillosis 1
• Consider empirical antifungal therapy with a mold-active agent (voriconazole, isavuconazole, or liposomal amphotericin B)

Monitoring and Duration

Continue antibiotics until:

• ANC recovers to >500 cells/mm³ with upward trend, AND
• Patient has been afebrile for at least 48 hours, AND
• All signs/symptoms of documented infection have resolved 1

Monitor closely:

• CBC every 3 days minimum 1
• Serum creatinine/BUN every 3 days 1
• Liver function tests weekly if complicated course 1
• Daily clinical assessment for new symptoms

Critical Pitfalls to Avoid

1. Do not delay antibiotics waiting for cultures—mortality increases significantly with delayed treatment 2
2. Do not use fluoroquinolone monotherapy if the patient was on fluoroquinolone prophylaxis 1
3. Do not perform rectal examination or use rectal thermometers—risk of bacteremia 1
4. Do not assume low-risk based solely on solid tumor diagnosis—this patient has multiple high-risk features 1
5. Do not discharge until neutrophil recovery begins and clinical stability is confirmed for at least 48 hours

Infection Control

• Place in private room if available 1
• Strict hand hygiene for all healthcare workers and visitors 1
• No fresh flowers or plants in room (mold risk) 1
• Exclude visitors with respiratory infections 1

This patient requires aggressive inpatient management given the constellation of severe neutropenia, active malignancy with concurrent chemoradiation, possible viral reactivation, and respiratory symptoms with potential airway involvement.